Sanofi Pasteur
Sanofi Pasteur is the vaccines division of sanofi-aventis Group. It is the largest company in the world devoted entirely to vaccines.
Source: Wikipedia
Lobbying
$1,036,000 SpentFigures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying On Behalf of Sanofi Pasteur
-
Names of Lobbyists
-
Firm Hired Amount Dalrymple & Assoc $276,000 American Capitol Group $240,000 DLA Piper $220,000 Twenty-First Century Group $180,000 Cornerstone Government Affairs $120,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Medical Research & Clin Labs,
- Pharmacy,
- Economics & Econ Development
-
Most Frequently Disclosed Bills
Bill No. Title H.RES.295 Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease. S.1884 School Access to Emergency Epinephrine Act H.R.3627 School Access to Emergency Epinephrine Act S.3274 Global Investment in American Jobs Act of 2012 H.R.5901 Catching Up To 1968 Act of 2012 H.R.5910 Global Investment in American Jobs Act of 2012
Regulations
2 MentionsAll data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Sanofi Pasteur" in public comments on proposed federal regulations.
-
Mentions in Document Text
Federal Spending
38 contractsFederal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.
Only grants, contracts and loans with amounts over $1 million are shown.
Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.
Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.
Type | Recipient Name | Year | Agency | Description | Amount |
---|---|---|---|---|---|
contract |
Sanofi Pasteur Inc. | 2012 | Centers For Disease Control | VFC 2012 | $238,187,549 |
contract |
Sanofi Pasteur Inc. | 2011 | Centers For Disease Control | VACCINE FOR CHILDREN 2011 | $179,036,768 |
contract |
Sanofi Pasteur Inc. | 2011 | Centers For Disease Control | VACCINE FOR CHILDREN 2011 | $152,464,626 |
contract |
Sanofi Pasteur Inc. | 2011 | Centers For Disease Control | TAS::75 0512::TAS 00HCVGBC-2010-82347 - SANOFI PEDIATRIC VACCINE CONTRACT | $149,339,018 |
contract |
Sanofi Pasteur Inc. | 2012 | Centers For Disease Control | VFC 2012 | $126,722,381 |
contract |
Sanofi Pasteur Inc. | 2011 | Centers For Disease Control | PEDIATRIC FLU VACCINCE CONTRACT | $121,150,296 |
contract |
Sanofi Pasteur Inc. | 2012 | Centers For Disease Control | SANOFI VFC 2011 | $117,966,403 |
contract |
Sanofi Pasteur Inc. | 2012 | Centers For Disease Control | PEDIATRIC VACCINE FLU VFC | $111,643,528 |
contract |
Sanofi Pasteur Inc. | 2012 | Centers For Disease Control | VFC 2012 | $104,401,132 |
contract |
Sanofi Pasteur Inc. | 2011 | Centers For Disease Control | VACCINCE FOR CHILDREN 2010 | $96,496,327 |
Advisory Committees
1 person on 1 committeeData is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Sanofi Pasteur" that sat on federal advisory committees.
View all advisory committee data for Sanofi Pasteur